Kersten Dirk's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Mar 11, 2026
- Accession no.
- 0001193125-26-102469
- Filed
- Mar 11, 2026
- Trade date
- Mar 9-10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $13.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kersten DirkCIK 0001823682 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Common Stock | SSaleDisposed | −177,690 | $17.72 | −$3,148,666.8 | 5,285,156 | Indirect | |
| Mar 10, 2026 | Common Stock | SSaleDisposed | −9,482 | $18.21 | −$172,667.22 | 5,275,674 | Indirect | |
| Mar 10, 2026 | Common Stock | SSaleDisposed | −219,758 | $19.33 | −$4,247,922.14 | 5,055,916 | Indirect | |
| Mar 10, 2026 | Common Stock | SSaleDisposed | −281,858 | $19.80 | −$5,580,788.4 | 4,774,058 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.